About the fund
Investment Advisor
Founders
Investors
Board of Directors
Business Advisory Board
Scientific Advisory Board
Management Team
Portfolio
AngioGenetics Sweden AB
CanAg Diagnostics AB
Cellectricon AB
Genizon BioSciences
Gyros AB
Independent Pharma. AB
NsGene A/S
Phasein AB
Sidec Technologies AB
Wilex
News
2008
2007
2006
2005
2004
2003
Investment Proposals
Contact
KAROLINSKA INVESTMENT FUND
is committed to generating superior capital returns for its investors
engages actively in defining goals
and strategies to create attractive companies with globally demanded products
invests in pharmaceutical, biotechnology and medical technology companies with a substantial commercial potential
contributes with scientific, financial and industrial expertise and
networks
is managed exclusively by
KI Management AB
has SEK 600 million under management
Phone
+46 8 50 88 44 50
Fax
+46 8 50 88 44 59
Email
marie-louise.sundin@
karolinskafund.com
